HEART Score in Practice – Randomized Trial
The HEART score is one safe way to help risk stratify chest pain patients.
No Advantage to Early Invasive Strategy for NSTEMI
There was no long-term advantage at 10 years to an early invasive vs selective invasive strategy strategy for NSTEMI.
More on hs-cTnT Plus Important Reader Comment
In this collection of studies, a non-ischemic ECG and single hs-cTnT performed well. Use caution with hs-cTnT in patients presenting with symptoms < 3 hours.
They’re Here… High Sensitivity Troponin
High sensitivity troponin may allow for a very rapid MI rule out.
ECGs Are Not Created Equal
ECG is never used alone for cardiac risk stratification, but some ECG findings are more concerning than others.
Safety of MRI with a Pacemaker-ICD
A non-thoracic MRI is not absolutely contraindicated, assuming proper interrogation and programming of the device is done before the scan.
Why We AFFIRM Rate Control for A-fib
Rhythm control for chronic a-fib had no advantage over rate control.
Anterior TWI – No Arrhythmia Risk
Anterior TWI in V1 and V2 appears to be a normal variant in young healthy white people, assuming no family history of arrhythmia.
Divided HEART – EM and Cardiology Disagree
Emergency Physicians' HEART score calculations and those of cardiology were not the same. EM scored the history as suspicious more often.
Bolus Nitroglycerin for CHF
This study suggests that in hypertensive patients with acute decompensated heart failure and shortness of breath, bolus IV NTG 1 or 2 mg was safe and reduced ICU admission and length of stay.